109 related articles for article (PubMed ID: 6191697)
1. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experiences with pepleomycin].
Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
[TBL] [Abstract][Full Text] [Related]
3. [Phase II trial of peplomycin in non-Hodgkin's lymphoma].
Sampi K; Kumai R; Hattori M; Kaneko Y; Sakurai M
Gan To Kagaku Ryoho; 1985 May; 12(5):1063-7. PubMed ID: 2581513
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy using peplomycin for the treatment of non-Hodgkin's lymphoma including adult T cell leukemia].
Kamihira S; Sakitani M; Nakano M; Kinoshita K; Ichimaru M
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):931-7. PubMed ID: 6191669
[TBL] [Abstract][Full Text] [Related]
5. [Clinical use of peplomycin in esophageal cancer].
Hirai T; Takiyama W; Miyoshi Y; Hattori T; Yamagata S; Ohya M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1249-55. PubMed ID: 6191710
[TBL] [Abstract][Full Text] [Related]
6. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
[TBL] [Abstract][Full Text] [Related]
7. [Treatment for advanced malignant lymphoma in patients with compromised bone marrow--a combination therapy using pepleomycin, vincristine and high-dose adrenocorticoids (POP regimen)].
Tamura K; Araki Y; Seita M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2568-72. PubMed ID: 6210054
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
10. A review of clinical studies of pepleomycin.
Oka S
Recent Results Cancer Res; 1980; 74():163-71. PubMed ID: 6160600
[TBL] [Abstract][Full Text] [Related]
11. Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
Dang NH; Hagemeister FB; Duvic M; Romaguera JE; Younes A; Jones D; Samuels B; Fayad LE; Pro B; Samaniego F; Sarris A; Goy A; McLaughlin P; Tong AT; Walker PL; Tiongson LP; Smith TL; Huh YO; Morimoto C; Rodriguez MA
Oncol Rep; 2003; 10(5):1513-8. PubMed ID: 12883733
[TBL] [Abstract][Full Text] [Related]
12. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
13. Effect of pepleomycin in prostatic cancer. A preliminary report.
Niijima T; Koiso K
Scand J Urol Nephrol Suppl; 1980; 55():177-9. PubMed ID: 6163206
[TBL] [Abstract][Full Text] [Related]
14. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
Akutsu M; Kano Y; Ogawa M; Miura A; Hirano M; Masaoka T; Tatsumi N
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
[TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
[TBL] [Abstract][Full Text] [Related]
17. [Clinical effect of Peplomycin on recurrent breast cancer].
Kimura M; Koida T; Fukuda T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1665-9. PubMed ID: 6191688
[TBL] [Abstract][Full Text] [Related]
18. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
19. [Clinical diagnosis and surgical treatment of primary pulmonary lymphoma].
Zhang LB; Sun YE; Yu CH; Liu Y
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):97-9. PubMed ID: 16620666
[TBL] [Abstract][Full Text] [Related]
20. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
